Cargando…

Strategies for Treating Latent Multiple-Drug Resistant Tuberculosis: A Decision Analysis

BACKGROUND: The optimal treatment for latent multiple-drug resistant tuberculosis infection remains unclear. In anticipation of future clinical trials, we modeled the expected performance of six potential regimens for treatment of latent multiple-drug resistant tuberculosis. METHODS: A computerized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holland, David P., Sanders, Gillian D., Hamilton, Carol D., Stout, Jason E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260212/ https://www.ncbi.nlm.nih.gov/pubmed/22272302 http://dx.doi.org/10.1371/journal.pone.0030194

Ejemplares similares

Potential Economic Viability of Two Proposed Rifapentine-Based Regimens for Treatment of Latent Tuberculosis Infection
por: Holland, David P., et al.
Publicado: (2011)

What Patient Factors Predict Physicians’ Decision Not to Treat Latent Tuberculosis Infection in Tuberculosis Contacts?
por: Dobler, Claudia C., et al.
Publicado: (2013)

Marine Natural Products and Drug Resistance in Latent Tuberculosis
por: Khan, Muhammad Tahir, et al.
Publicado: (2019)

752. Geographic Analysis of Latent Tuberculosis Screening: A Health System Approach
por: Bonnewell, John, et al.
Publicado: (2018)

Geographic analysis of latent tuberculosis screening: A health system approach
por: Bonnewell, John P., et al.
Publicado: (2020)

Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection
por: Dobler, Claudia C., et al.
Publicado: (2018)

Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection
por: Shleider Carnero Canales, Christian, et al.
Publicado: (2023)

Current management options for latent tuberculosis: a review
por: Norton, Brianna L, et al.
Publicado: (2012)

A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent Tuberculosis
por: Banerjee, Ushashi, et al.
Publicado: (2020)

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
por: Pérez-Lago, Laura, et al.
Publicado: (2015)

Uncovering the hidden: complexity and strategies for diagnosing latent tuberculosis
por: Flores-Valdez, Mario Alberto
Publicado: (2017)

Extrapulmonary tuberculosis, human immunodeficiency virus, and foreign birth in North Carolina, 1993 – 2006
por: Kipp, Aaron M, et al.
Publicado: (2008)

Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies
por: Rebeiro, Peter F., et al.
Publicado: (2020)

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization
por: Eedara, Basanth Babu, et al.
Publicado: (2023)

Latent tuberculosis
por: Koul, Ajaz Nabi
Publicado: (2016)

Latent and Active Tuberculosis: Evaluation of Injecting Drug Users
por: Mamani, Mojgan, et al.
Publicado: (2013)

A Collaborative Approach to Treatment Strategies for Latent Tuberculosis Infection
por: Lal, Amos, et al.
Publicado: (2020)

Tuberculosis Infection and Latent Tuberculosis
por: Lee, Seung Heon
Publicado: (2016)

The ongoing challenge of latent tuberculosis
por: Esmail, H., et al.
Publicado: (2014)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Strategies to Combat Multi-Drug Resistance in Tuberculosis
por: Singh, Vinayak, et al.
Publicado: (2021)

Fluoroquinolone-resistant latent tuberculosis infection: A literature review and case series of 5 patients treated with linezolid monotherapy
por: Baker, Jacob J., et al.
Publicado: (2023)

Multiple drugs: Latent tuberculosis (TB) reactivation, lack of efficacy and off-label use: case report
Publicado: (2021)

Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study
por: Goswami, Neela D, et al.
Publicado: (2012)

The Treatment of Latent Tuberculosis
Publicado: (1905)

The diagnosis and treatment of latent tuberculosis by nurses in Brazil: a necessary strategy
por: Arcêncio, Ricardo Alexandre, et al.
Publicado: (2022)

Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy
por: Gong, Wenping, et al.
Publicado: (2021)

Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis
por: Goel, Divya
Publicado: (2014)

Mathematical modelling of the impact of treating latent tuberculosis infection in the elderly in a city with intermediate tuberculosis burden
por: Chong, Ka Chun, et al.
Publicado: (2019)

Completion of Treatment for Latent Tuberculosis Infection with Monthly Drug Dispensation Directly through the Tuberculosis Clinic
por: Dobler, Claudia C., et al.
Publicado: (2012)

Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients
por: Acquah, Rebecca, et al.
Publicado: (2021)

Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong
por: Wong, Ngai Sze, et al.
Publicado: (2019)

Latent tuberculosis infection and tuberculosis in children and adolescents
por: Ishikawa, Cassia Satsuki, et al.
Publicado: (2018)

Treatment of Latent Tuberculosis Infection
por: Tang, Patrick, et al.
Publicado: (2017)

Immune Subtyping in Latent Tuberculosis
por: Banerjee, Ushashi, et al.
Publicado: (2021)

Latent Tuberculosis in India: An Overview
por: Vishwakarma, Deepak, et al.
Publicado: (2023)

Current strategies to treat tuberculosis
por: Podany, Anthony T., et al.
Publicado: (2016)

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
por: Leibert, Eric, et al.
Publicado: (2014)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_emn5mvd0550r6uc8gdnbeppcup